Impact of SGLT2i and GLP-1RA on liver-related events in patients with MASLD and type 2 diabetes: A network meta-analysis

Authors

Chi‐Ho Lee (ORCID: https://orcid.org/0000-0002-7569-409X)
Rex Wan‐Hin Hui (ORCID: https://orcid.org/0000-0001-7447-7539)
Xianhua Mao (ORCID: https://orcid.org/0000-0003-4050-4759)
Lung‐Yi Mak (ORCID: https://orcid.org/0000-0002-2266-3935)
Ka Shing Cheung (ORCID: https://orcid.org/0000-0002-4838-378X)
Man‐Fung Yuen (ORCID: https://orcid.org/0000-0001-7985-7725)
Lu Li (ORCID: https://orcid.org/0000-0002-3044-0838)
Wai‐Kay Seto (ORCID: https://orcid.org/0000-0002-9012-313X)
David Tak Wai Lui (ORCID: https://orcid.org/0000-0002-9813-1126)

Institutions

Chinese University of Hong Kong (HK)
Stanford Medicine (US)
University of Hong Kong - Shenzhen Hospital (CN)
University of Hong Kong (HK)
Stanford University (US)

Publication Details

Journal: JHEP Reports
Published: 2025-11-05
DOI: https://doi.org/10.1016/j.jhepr.2025.101661
Primary Topic: Diabetes Treatment and Management
Type: article
Field-Weighted Citation Impact: 0.00

Funders

Amgen
Eli Lilly and Company
Pfizer
AstraZeneca
Sanofi
Gilead Sciences
Alexion Pharmaceuticals
Lee Foundation
Arrowhead Pharmaceuticals
Sysmex Corporation

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Impact of SGLT2i and GLP-1RA on liver-related events in patients with MASLD and type 2 diabetes: A network meta-analysis

Chi‐Ho Lee, Rex Wan‐Hin Hui, Xianhua Mao, Lung‐Yi Mak et al.

Nov 5, 2025

JHEP Reports

Diabetes Treatment and Management

article

Impact of SGLT2i and GLP-1RA on liver-related events in patients with MASLD and type 2 diabetes: A network meta-analysis

Chi‐Ho Lee, Rex Wan‐Hin Hui, Xianhua Mao, Lung‐Yi Mak, Ka Shing Cheung, Man‐Fung Yuen, Lu Li, Wai‐Kay Seto, David Tak Wai Lui

November 5, 2025article en

Abstract

No abstract available for this paper.

JHEP ReportsVol. 8(1)

Chinese University of Hong Kong (HK), Stanford Medicine (US), University of Hong Kong - Shenzhen Hospital (CN), University of Hong Kong (HK), Stanford University (US)

Amgen, Eli Lilly and Company, Pfizer, AstraZeneca, Sanofi, Gilead Sciences, Alexion Pharmaceuticals, Lee Foundation, Arrowhead Pharmaceuticals, Sysmex Corporation

Openalex Percentile: Top 56%

Diabetes Treatment and Management

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Impact of SGLT2i and GLP-1RA on liver-related events in patients with MASLD and type 2 diabetes: A network meta-analysis — Chi‐Ho Lee, Rex Wan‐Hin Hui, et al. · JHEP Reports (2025) | TGRS Research Map | TGRS